Results 131 to 140 of about 50,061 (215)
Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type, With Rapid Systemic Progression in an Elderly Patient: A Case Report. [PDF]
Solorio Rivera AH +4 more
europepmc +1 more source
Rapidly progressive adult-onset hydroa vacciniforme-like lymphoproliferative disorder associated with Epstein-Barr virus: a case report. [PDF]
Deng J +5 more
europepmc +1 more source
What Is Your Diagnosis? Lymph Node Aspirate From a Dog
Veterinary Clinical Pathology, EarlyView.
William Benedict +3 more
wiley +1 more source
Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas +16 more
wiley +1 more source
Contralateral Cutaneous T-cell Lymphoma as a Mimicker of Multi-decade Atopic Dermatitis. [PDF]
Dasher A +6 more
europepmc +1 more source
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller +9 more
wiley +1 more source
Malignant histiocytic neoplasm with dendritic differentiation via transdifferentiation of B-cell lymphoma. [PDF]
Wu C, Cui W, Tun AM.
europepmc +1 more source
ABSTRACT Background Component C1q binding protein (C1QBP) is known as an important regulator of mitochondrial plasticity and is involved in antitumor immune response in cancers. Nevertheless, its role in lung adenocarcinoma (LUAD) still remains largely unknown.
Wei Li +9 more
wiley +1 more source
Romidepsin (RMD), an FDA‐approved histone deacetylase inhibitor for treating cancer, demonstrates potent latency‐reversing activity in vitro but has yielded suboptimal outcomes in kick‐and‐kill HIV‐cure trials when administered as a 5 mg/m2 infusion.
Lauren A. R. Tompkins +7 more
wiley +1 more source
Morphologic mimicry of cutaneous T-cell lymphoma as classic Hodgkin lymphoma-a case report. [PDF]
Lunt J, Burns R, Schammel CM, Knight J.
europepmc +1 more source

